(Q39436443)

12 September 2017

Exendin-4 attenuates lipopolysaccharides induced inflammatory response but does not protects H9c2 cells from apoptosis (English)

1 reference

12 September 2017

0 references

0 references

0 references

Tien-Hsing Chen

1

1 reference

12 September 2017

Hung-Ta Wo

2

1 reference

12 September 2017

Chien-Chia Wu

3

1 reference

12 September 2017

Jian-Liang Wang

4

1 reference

12 September 2017

Chun-Chieh Wang

5

1 reference

12 September 2017

I-Chang Hsieh

6

1 reference

12 September 2017

Cheng-Yi Kuo

7

1 reference

12 September 2017

Chien Ting Liu

8

1 reference

12 September 2017

29 November 2011

1 reference

Immunopharmacology and Immunotoxicology

12 September 2017

1 reference

12 September 2017

34

1 reference

12 September 2017

3

1 reference

12 September 2017

484-490

1 reference

Cardioprotective and vasodilatory actions of glucagon-like peptide 1 receptor are mediated through both glucagon-like peptide 1 receptor-dependent and -independent pathways

12 September 2017

1 reference

https://api.crossref.org/works/10.3109%2F08923973.2011.630398

Glucagon-like peptide-1 relaxes rat conduit arteries via an endothelium-independent mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08923973.2011.630398

Preclinical and Clinical Data on Extraglycemic Effects of GLP-1 Receptor Agonists

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08923973.2011.630398

GLP-1R agonist liraglutide activates cytoprotective pathways and improves outcomes after experimental myocardial infarction in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08923973.2011.630398

Effects of glucagon-like peptide-1 on endothelial function in type 2 diabetes patients with stable coronary artery disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08923973.2011.630398

A glucagon-like peptide-1 (GLP-1) analogue, liraglutide, upregulates nitric oxide production and exerts anti-inflammatory action in endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08923973.2011.630398

Suppressive effects of glucagon-like peptide-1 on interferon-gamma-induced nitric oxide production in insulin-producing cells is mediated by inhibition of tumor necrosis factor-alpha production

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08923973.2011.630398

Exendin-4 protects beta-cells from interleukin-1 beta-induced apoptosis by interfering with the c-Jun NH2-terminal kinase pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08923973.2011.630398

Glucagon-like peptide-1 receptor agonist ameliorates renal injury through its anti-inflammatory action without lowering blood glucose level in a rat model of type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08923973.2011.630398

Sepsis-induced myocardial dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08923973.2011.630398

Inflammatory biomarkers in heart failure revisited: much more than innocent bystanders

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08923973.2011.630398

Role of bacterial endotoxin in chronic heart failure: the gut of the matter.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08923973.2011.630398

LPS/TLR4 signal transduction pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08923973.2011.630398

Advances in research of the inflammatory response: the importance of toll-like receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08923973.2011.630398

Escherichia coli LPS-induced LV dysfunction: role of toll-like receptor-4 in the adult heart.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08923973.2011.630398

CD14-deficient mice are protected against lipopolysaccharide-induced cardiac inflammation and left ventricular dysfunction.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08923973.2011.630398

Toll-like receptor 4 stimulation initiates an inflammatory response that decreases cardiomyocyte contractility

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08923973.2011.630398

Toll-like receptor stimulation in cardiomyoctes decreases contractility and initiates an NF-kappaB dependent inflammatory response

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08923973.2011.630398

Myocardial matrix remodeling and the matrix metalloproteinases: influence on cardiac form and function

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08923973.2011.630398

Lipopolysaccharide upregulates uPA, MMP-2 and MMP-9 via ERK1/2 signaling in H9c2 cardiomyoblast cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08923973.2011.630398

Therapeutic potential of anticytokine therapy in congestive heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08923973.2011.630398

Tumor necrosis factor-alpha gene and protein expression in adult feline myocardium after endotoxin administration

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08923973.2011.630398

Carthamus tinctorius L. prevents LPS-induced TNFalpha signaling activation and cell apoptosis through JNK1/2-NFkappaB pathway inhibition in H9c2 cardiomyoblast cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08923973.2011.630398

Akt mediates 17beta-estradiol and/or estrogen receptor-alpha inhibition of LPS-induced tumor necresis factor-alpha expression and myocardial cell apoptosis by suppressing the JNK1/2-NFkappaB pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08923973.2011.630398

Matrix metalloproteinase activities are altered in the heart and plasma during endotoxemia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08923973.2011.630398

Attenuation by creatine of myocardial metabolic stress in Brattleboro rats caused by chronic inhibition of nitric oxide synthase

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08923973.2011.630398

Cardiac and regional haemodynamics, inducible nitric oxide synthase (NOS) activity, and the effects of NOS inhibitors in conscious, endotoxaemic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08923973.2011.630398

Endothelial dysfunction, oxidative stress, and risk of cardiovascular events in patients with coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08923973.2011.630398

Comparison of gamma interferon-mediated antichlamydial defense mechanisms in human and mouse cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08923973.2011.630398

Inhibitory effects of epicatechin on interleukin-1beta-induced inducible nitric oxide synthase expression in RINm5F cells and rat pancreatic islets by down-regulation of NF-kappaB activation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08923973.2011.630398

10.3109/08923973.2011.630398

21 January 2018

Identifiers

DOI

1 reference

12 September 2017

1 reference